EUCTR2007-004544-73-DE进行中（未招募）不适用
A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Healthy female volunteer
- •Age: 18 – 35 years (inclusive) at the first screening examination
- •Willingness to use non-hormonal methods of contraception during the entire study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Contraindications for use of a combined (estrogen/progestogen) contraceptive (e.g. history of venous/arterial thromboembolic disease)
- •Regular intake of medication
- •Clinically relevant findings (ECG, blood pressure, physical, gynecological examination, laboratory examination)
- •Anovulatory pre-treatment cycle
研究者
相似试验
已完成
Unknown
A study to evaluate skin moisturization.CTRI/2023/05/052885Sami-Sabinsa Group Ltd30
已完成
Unknown
A study to evaluate skin moisturization.CTRI/2023/04/052081Abbott India Limited30
进行中（未招募）
不适用
A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid® 20 mg vs. Losec® 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy. - Zegerid® vs. Losec® in the rapid relief of heartburn associated with GERDHeartburn associated with gastro-oesophageal reflux disease (GERD)EUCTR2010-022082-10-GBorgine Ltd300
进行中（未招募）
不适用
A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid® 20 mg vs. Losec® 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy.Heartburn associated with gastro-oesophageal reflux disease (GERD)MedDRA version: 12.1Level: LLTClassification code 10018203Term: GERDMedDRA version: 12.1Level: LLTClassification code 10019326Term: HeartburnEUCTR2010-022082-10-HUorgine Ltd300
进行中（未招募）
不适用
A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid® 20 mg vs. Losec® 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy.Heartburn associated with gastro-oesophageal reflux disease (GERD)MedDRA version: 12.1Level: LLTClassification code 10018203Term: GERDMedDRA version: 12.1Level: LLTClassification code 10019326Term: HeartburnEUCTR2010-022082-10-BGorgine Ltd300